DOCSLIB.ORG

Maternal and Fetal Evaluation and Immediate Newborn Care

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Maternal and Fetal Evaluation and Immediate Newborn Care Time-efficient, cost-effective perinatal education and training PCEP Perinatal Continuing Education Program, 3rd Edition, Book I Continuing 3rd Edition, Education Perinatal Program, PCEP PCEP Perinatal Continuing Education Program BOOK Perinatal Continuing Education Program, 3rd Edition I 3RD EDITION EDITOR IN CHIEF, NEONATOLOGY Robert A. Sinkin, MD, MPH, FAAP PCEP Workbook Contents EDITOR IN CHIEF, OBSTETRICS EARN UP TO Christian A. Chisholm, MD, FACOG 54 CME MATERNAL AND FETAL EVALUATION AND IMMEDIATE CREDITS OR NEWBORN CARE (BOOK I) • Is the Mother Sick? Is the Fetus Sick? For more than 35 years, the Perinatal CONTACT HOURS! • Fetal Age, Growth, and Maturity Continuing Education Program (PCEP) • Fetal Well-being Maternal and Fetal has enhanced the knowledge and skills of • Is the Baby Sick? physicians, nurses, nurse midwives and • Resuscitating the Newborn practitioners, respiratory therapists, and other • Gestational Age and Size and Associated Risk Factors providers of care for pregnant women and newborns. • Thermal Environment • Hypoglycemia Evaluation and Immediate The third edition PCEP workbooks have been brought up-to-date with leading-edge procedures and techniques. These information-rich MATERNAL AND FETAL CARE (BOOK II) • Hypertensive Disorders of Pregnancy volumes are filled with concise information, step-by-step instructions, • Obstetric Hemorrhage and practice-focused exercises. They offer time-saving, low-cost • Perinatal Infections solutions for self-paced learning or as adjuncts to instructor-led Newborn Care • Other High-risk Conditions skills teaching. • Abnormal Glucose Tolerance PCEP IS A PROVEN EDUCATIONAL TOOL FOR • Premature Rupture or Infection of the Amniotic • Improving perinatal care know-how, policies, practices, and Membranes procedures. • Preterm Labor • Teaching both practical skills and cognitive knowledge. • Inducing and Augmenting Labor • Abnormal Labor Progress and Difficult Deliveries • Saving time—self-paced self-study approach streamlines the • Imminent Delivery and Preparation for Maternal/ learning process. Fetal Transport • Saving money—provide top-notch education at low per-participant costs. NEONATAL CARE (BOOK III) • Oxygen • Encouraging cooperation and communication among diverse • Respiratory Distress specialties and staffing levels. • Umbilical Catheters • Simplifying education planning and budgeting. • Low Blood Pressure • Intravenous Therapy CONVENIENT, HASSLE-FREE CME OR CONTACT HOURS • Feeding • Hyperbilirubinemia AMA PRA Category 1 Credit(s)™ or ANCC contact hours • Infections are available from the University of Virginia. Visit www.cmevillage.com for more information. • Review: Is the Baby Sick? Identifying and Caring for Sick and At-Risk Babies The University of Virginia School of Medicine is accredited by • Preparation for Neonatal Transport the Accreditation Council for Continuing Medical Education Earn to provide continuing medical education for physicians. SPECIALIZED NEWBORN CARE (BOOK IV) CME credits The University of Virginia School of Nursing is accredited as • Direct Blood Pressure Measurement a provider of continuing nursing education by the American • Exchange, Reduction, and Direct Transfusions or contact Nurses Credentialing Center’s Commission on Accreditation. • Continuous Positive Airway Pressure • Assisted Ventilation With Mechanical Ventilators hours! • Surfactant Therapy THE PCEP WORKBOOKS AND RELATED PRODUCTS CAN BE PURCHASED DIRECTLY • Continuing Care for At-Risk Babies FROM THE AMERICAN ACADEMY OF PEDIATRICS AT SHOP.AAP.ORG. AAP PCEP Perinatal Continuing Education Program Maternal and Fetal Evaluation and Immediate Newborn Care BOOK I 00a_FM_BKI_PCEP_i-viii.indd 1 9/2/16 3:56 PM American Academy of Pediatrics Publishing Staff The original version of these self-instructional Mark Grimes, Director, Department of Publishing books was developed in 1978 at the Eileen Glasstetter, MS, Manager, Product Development University of Virginia under contract Theresa Wiener, Manager, Publishing and Production (#N09-HR-2926) from the National Heart, Services Lung, and Blood Institute. Subsequent Jason Crase, Manager, Editorial Services versions have been developed independently Amanda Helmholz, Editorial Specialist by the authors and, for the current edition, an Peg Mulcahy, Manager, Graphic Design and Production editorial board. Mary Lou White, Director, Department of Marketing and Original PCEP Authors Sales John Kattwinkel, MD, FAAP Linda Smessaert, MSIMC, Marketing Manager, Professional Lynn J. Cook, RNC, MPH Publications Hallam Hurt, MD, FAAP George A. Nowacek, PhD Published by the American Academy of Pediatrics Jerry G. Short, PhD 141 Northwest Point Blvd Elk Grove Village, IL 60007-1019 Original Primary Authors for the Obstetric Telephone: 847/434-4000 Content Facsimile: 847/434-8000 Warren Crosby, MD www.aap.org Lynn J. Cook, RNC, MPH Information about obtaining continuing medical education and continuing education credit for book study may be obtained by visiting www.cmevillage.com. Several different approaches to specific perinatal problems may be acceptable. The PCEP books have been written to present specific recommendations rather than to include all currently acceptable options. The recommendations in these books should not be considered the only accepted standard of care. We encourage development of local standards in consultation with your regional perinatal center staff. Statements and opinions expressed are those of the authors and not necessarily those of the American Academy of Pediatrics. Every effort has been made to ensure that the drug selection and dosage set forth in this text are in accordance with the current recommendations and practice at time of publication. It is the responsibility of the health care professional to check the package insert of each drug for any change in indications and dosage and for added warnings and precautions. Products and Web sites are mentioned for informational purposes only and do not imply an endorsement by the American Academy of Pediatrics. Web site addresses are as current as possible but may change at any time. Brand names are furnished for identification purposes only. No endorsement of the manufacturers or products mentioned is implied. No commercial involvement of any kind has been solicited or accepted in development of the content of this publication. The publishers have made every effort to trace the copyright holders for borrowed materials. If they have inadvertently overlooked any, they will be pleased to make the necessary arrangements at the first opportunity. Special discounts are available for bulk purchases of this publication. E-mail our Special Sales Department at [email protected] for more information. © 2017 University of Virginia Patent Foundation All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means—electronic, mechanical, photocopying, recording, or otherwise—without prior permission from the publisher (locate title at http://ebooks.aappublications.org and click on © Get Permissions; you may also fax the permissions editor at 847/434-8780 or e-mail [email protected]). First American Academy of Pediatrics edition published 2007; second, 2012. Original edition © 1978 University of Virginia. Printed in the United States of America 5-280/1016 1 2 3 4 5 6 7 8 9 10 PC0019 ISBN: 978-1-61002-052-7 eBook: 978-1-61002-053-4 Library of Congress Control Number: 2016932958 00a_FM_BKI_PCEP_i-viii.indd 2 9/2/16 3:56 PM Perinatal Continuing Education Program (PCEP), 3rd Edition Textbook Editorial Board Editors Editor in Chief, Neonatology Editor in Chief, Obstetrics Robert A. Sinkin, MD, MPH, FAAP Christian A. Chisholm, MD, FACOG Charles Fuller Professor of Neonatology Associate Professor of Obstetrics and Gynecology Division Head, Neonatology Vice Chair for Education Medical Director for Newborn Services Medical Director, Labor and Delivery Department of Pediatrics University of Virginia Medical Center University of Virginia Children’s Hospital Charlottesville, VA Charlottesville, VA PCEP Editorial Board Members Lorie Banker, BSN, RNC Barbara O’Brien, RN, MS Care Coordinator Program Director Golisano Children’s Hospital Office of Perinatal Quality Improvement Rochester, NY The University of Oklahoma Health Sciences Center Melissa F. Carmen, MD, FAAP Oklahoma City, OK Assistant Professor of Pediatrics Division of Neonatology Chad Michael Smith, MD University of Rochester Medical Center Associate Professor of Obstetrics & Gynecology Rochester, NY Medical Director, Labor & Delivery Medical Director, Perinatal Patient Safety Susan B. Clarke, MS, RNC-NIC, RN-BC, CNS University of Oklahoma Health Sciences Center Professional Development Specialist Medical Director, Oklahoma Perinatal Quality Continuing Education and Outreach Improvement Collaborative Primary Nurse Planner Oklahoma City, OK Children’s Hospital Colorado Aurora, CO Jonathan R. Swanson, MD, MSc, FAAP Associate Professor of Pediatrics Ann Kellams, MD, FAAP, IBCLC, FABM Division of Neonatology Associate Professor, Department of Pediatrics Chief Quality Officer for Children’s Services Director, Well Newborn and Breastfeeding Medical Director, Neonatal Intensive Care Unit Medicine Services University of Virginia Children’s Hospital University of Virginia Children’s Hospital Charlottesville, VA Charlottesville, VA Sharon Veith, MSN, RN Sally Ann Miller, CNM, NP Assistant Professor Advanced Practice Registered Nurse University of Virginia School of Nursing
Load more

Recommended publications
  • Pre-Term Pre-Labour Rupture of Membranes and the Role of Amniocentesis
    Fetal and Maternal Medicine Review 2010; 21:2 75–88 C Cambridge University Press 2010 doi:10.1017/S096553951000001X First published online 15 March 2010 PRE-TERM PRE-LABOUR RUPTURE OF MEMBRANES AND THE ROLE OF AMNIOCENTESIS 1,2 ANNA P KENYON, 1,2 KHALIL N ABI-NADER AND 2 PRANAV P PANDYA 1Elizabeth Garrett Anderson Institute for Women’s Health, University College London, 86-96 Chenies Mews, London WCIE 6NX. 2Fetal Medicine Unit, University College London Hospitals NHS Foundation Trust, 235 Euston Rd, London NWI 2BU. INTRODUCTION Pre-labour premature rupture of membranes (PPROM) is defined as rupture of membranes more than 1 hour prior to the onset of labour at <37 weeks gestation. PPROM occurs in approximately 3% of pregnancies and is responsible for a third of all preterm births.1 Once membranes are ruptured prolonging the pregnancy has no maternal physical advantage but fetal morbidity and mortality are improved daily at early gestations: 19% of those infants born <25 weeks develop cerebral palsy (CP) and 28% have severe motor disability.2 Those infants born extremely pre term (<28 weeks) cost the public sector £75835 (95% CI £27906–145508) per live birth3 not to mention the emotional cost to the family. To prolong gestation is therefore the suggested goal: however how and why might we delay birth in those at risk? PPROM is one scenario associated with preterm birth and here we discuss the causative mechanisms, sequelae, latency, strategies to prolong gestation (antibiotics) and consider the role of amniocentesis. We will also discuss novel therapies. PATHOPHYSIOLOGY OF MEMBRANE RUPTURE The membranes, which act to protect and isolate the fetus, are composed of two layers.
    [Show full text]
  • 15 Complications of Labor and Birth 279
    Complications of 15 Labor and Birth CHAPTER CHAPTER http://evolve.elsevier.com/Leifer/maternity Objectives augmentation of labor (a˘wg-me˘n-TA¯ -shu˘n, p. •••) Bishop score (p. •••) On completion and mastery of Chapter 15, the student will be able to do cephalopelvic disproportion (CPD) (se˘f-a˘-lo¯ -PE˘L- v i˘c the following: di˘s-pro¯ -PO˘ R-shu˘n, p. •••) 1. Defi ne key terms listed. cesarean birth (se˘-ZA¯ R-e¯-a˘n, p. •••) 2. Discuss four factors associated with preterm labor. chorioamnionitis (ko¯ -re¯-o¯-a˘m-ne¯-o¯ -NI¯-ti˘s, p. •••) 3. Describe two major nursing assessments of a woman dysfunctional labor (p. •••) ˘ ¯ in preterm labor. dystocia (dis-TO-se¯-a˘, p. •••) episiotomy (e˘-pe¯ z-e¯-O˘ T- o¯ -me¯, p. •••) 4. Explain why tocolytic agents are used in preterm labor. external version (p. •••) 5. Interpret the term premature rupture of membranes. fern test (p. •••) 6. Identify two complications of premature rupture of forceps (p. •••) membranes. hydramnios (hi¯-DRA˘ M-ne¯-o˘s, p. •••) 7. Differentiate between hypotonic and hypertonic uterine hypertonic uterine dysfunction (hi¯-pe˘r-TO˘ N-i˘k U¯ -te˘r-i˘n, dysfunction. p. •••) 8. Name and describe the three different types of breech hypotonic uterine dysfunction (hi¯-po¯-TO˘ N-i˘k, p. •••) presentation. induction of labor (p. •••) ¯ 9. List two potential complications of a breech birth. multifetal pregnancy (mu˘l-te¯-FE-ta˘l, p. •••) nitrazine paper test (NI¯-tra˘-ze¯n, p. •••) 10. Explain the term cephalopelvic disproportion (CPD), and oligohydramnios (p. •••) discuss the nursing management of CPD.
    [Show full text]
  • Alessandro Ghidini, M.D. Fellow, ACOG
    Updated January 2021 Alessandro Ghidini, M.D. Fellow, ACOG Personal Information Education: 1971-1976 B.A. Liceo Classico "Arnaldo" (Brescia) Brescia, Italy 1976-82 Doctor in Medicine, Cum Laude University of Milan Via Festa del Perdono 17 Milan, Italy 1984-1988 Residency in Obstetrics and Gynecology University of Milan, Italy 1986-1987 Post-doctoral Fellowship Department of Obstetrics and Gynecology Yale University School of Medicine, CT 1987-1991 Residency in Obstetrics and Gynecology Yale-New Haven Hospital, New Haven, CT Chair: Frederick Naftolin 1991-1992 Fellowship in Medical and Molecular Genetics Mount Sinai School of Medicine New York, NY Chair: Robert Desnick 1992-1994 Fellowship in Maternal Fetal Medicine Mount Sinai School of Medicine New York, New York Chair: Richard L. Berkowitz Professional Experience 7/1994-6/1996 Assistant Professor, Maternal-Fetal Medicine Section, Perinatal Research Facility, 1 Updated January 2021 Georgetown University Medical Center, Washington, D.C. (NIH contract # NO1-HD-3-3198) 7/1996-3/2000 Assistant Professor, Department of Obstetrics and Gynecology, Georgetown University Medical Center, Washington, D.C. 1/1999-10/2004 Director of Perinatal Research, Department of Obstetrics and Gynecology, Georgetown University School of Medicine 3/2000-10/2007 Associate Professor, Department of Obstetrics and Gynecology, Georgetown University Medical Center, Washington, D.C. 10/2007-present Professor, Clinician Scholar track Department of Obstetrics and Gynecology, Georgetown University Medical Center, Washington, D.C. 2004-2011 Adjunct Professor University of Milano-Bicocca Monza, Italy 7/2009-2011 Affiliate Program Director Maternal Fetal Medicine Fellowship Program Washington Hospital Center, Washington, D.C. 11/2004-2019 Medical Director, Antenatal Testing Center, Inova Alexandria Hospital, Alexandria, VA 2 Updated January 2021 Honors and Awards 1986-1988 Milan University Research Fellowship 1991 Meehan-Miller Award Yale New Haven Medical Center Outstanding Chief Resident 1994 Contemporary Ob.
    [Show full text]
  • Original Article
    Mak Med Pregled 2016; 70(2): 153-157 DOI: 10.1515/mmr-2016-0029 MMP Original article NON-INVASIVE PRENATAL DETERMINATION OF FETAL MATURITY Elena Dzikova1, Goran Dimitrov1 and Olivera Stojceva-Taneva2 1University Clinic for Gynecology and Obstetrics, 2University Clinic of Nephrology, Medical Faculty, University Ss. “Cyril and Methodius”, Skopje, Republic of Macedonia Abstract lack of surfactant causes increased surface tension of the alveoli. That process reduces the possibility of Aims. The prenatal prediction of fetal maturity is very their expansion thus preventing the establishment of important, since neonatal respiratory distress syndrome the process of breathing, described as a major etiological (RDS) is one of the biggest causes of neonatal mortality. factor for hyaline membrane disease in the study of Our aim was to investigate a new non-invasive method Avery and Mead by 1959. [1]; Mahaffey et al. in 1959. for prediction of fetal maturity and to determine in which [2]; Adams et al. 1967. [3]; Northway et al. 1967. [4]. group according to gestational age of the fetus, the treat- In the process of maturation, fetal lungs are the most ment works the best and in which cases it is necessary important organ for survival in extra uterine environ- to be repeated. ment. Therefore, it is very important to predict the fe- Methods. We examined 60 patients (30 with impending tal maturity prenatally, in order to provide adequate preterm delivery, divided in 3 groups: 28-30, 30-32, and 32- treatment to improve fetal maturity, and thus postpar- 34 gestational weeks and 30 controls), at the University tum adaptation of the fetus, as well as to reduce morbi- Clinic for Gynecology and Obstetrics, Medical Faculty, Uni- dity and mortality in the newborn.
    [Show full text]
  • Estimation of Early Life Endogenous Surfactant Pool and CPAP Failure In
    Raschetti et al. Respiratory Research (2019) 20:75 https://doi.org/10.1186/s12931-019-1040-z RESEARCH Open Access Estimation of early life endogenous surfactant pool and CPAP failure in preterm neonates with RDS Roberto Raschetti1†, Roberta Centorrino1†, Emmanuelle Letamendia1,2,3, Alexandra Benachi2, Anne Marfaing-Koka3 and Daniele De Luca1,4* Abstract Background: It is not known if the endogenous surfactant pool available early in life is associated with the RDS clinical course in preterm neonates treated with CPAP. We aim to clarify the clinical factors affecting surfactant pool in preterm neonates and study its association with CPAP failure. Methods: Prospective, pragmatic, blind, cohort study. Gastric aspirates were obtained (within the first 6 h of life and before the first feeding) from 125 preterm neonates with RDS. Surfactant pool was measured by postnatal automated lamellar body count based on impedancemetry, without any pre-analytical treatment. A formal respiratory care protocol based on European guidelines was applied. Clinical data and perinatal risk factors influencing RDS severity or lamellar body count were real-time recorded. Investigators performing lamellar body count were blind to the clinical data and LBC was not used in clinical practice. Results: Multivariate analysis showed gestational age to be the only factor significantly associated with lamellar body count (standardized β:0.233;p = 0.023). Lamellar body count was significantly higher in neonates with CPAP success (43.500 [23.750–93.750]bodies/μL), than in those failing CPAP (20.500 [12.250–49.750] bodies/μL;p = 0.0003). LBC had a moderate reliability to detect CPAP failure (AUC: 0.703 (0.615–0.781);p < 0.0001; best cut-off: ≤30,000 bodies/μL).
    [Show full text]
  • Obstetrics Seventh Edition
    PROLOGObstetrics seventh edition The American College of Obstetricians and Gynecologists WOMEN’S HEALTH CARE PHYSICIANS Obstetrics seventh edition Assessment Book The American College of Obstetricians and Gynecologists WOMEN’S HEALTH CARE PHYSICIANS ISBN 978-1-934984-22-2 Copyright 2013 by the American College of Obstetricians and Gynecologists. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, posted on the Internet, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the publisher. 12345/76543 The American College of Obstetricians and Gynecologists 409 12th Street, SW PO Box 96920 Washington, DC 20090-6920 Contributors PROLOG Editorial and Advisory Committee CHAIR MEMBERS Ronald T. Burkman Jr, MD Bernard Gonik, MD Professor of Obstetrics and Professor and Fann Srere Chair of Gynecology Perinatal Medicine Tufts University School of Medicine Division of Maternal–Fetal Medicine Division of General Obstetrics and Department of Obstetrics and Gynecology Gynecology Department of Obstetrics and Wayne State University School of Gynecology Medicine Baystate Medical Center Detroit, Michigan Springfield, Massachusetts Louis Weinstein, MD Past Paul A. and Eloise B. Bowers Professor and Chair Department of Obstetrics and Gynecology Thomas Jefferson University Philadelphia, Pennsylvania Linda Van Le, MD Leonard Palumbo Distinguished Professor UNC Gynecologic Oncology University of North Carolina School of Medicine Chapel Hill, North Carolina PROLOG Task Force for Obstetrics, Seventh Edition COCHAIRS MEMBERS Vincenzo Berghella, MD Cynthia Chazotte, MD Director, Division of Maternal–Fetal Professor of Clinical Obstetrics and Medicine Gynecology and Women’s Health Professor, Department of Obstetrics Department of Obstetrics and Gynecology and Gynecology Weiler Hospital of the Albert Einstein Thomas Jefferson University College of Medicine Philadelphia, Pennsylvania Bronx, New York George A.
    [Show full text]
  • AVIS Ce Document a Été Numérisé Par La Division De La Gestion Des
    Direction des bibliothèques AVIS Ce document a été numérisé par la Division de la gestion des documents et des archives de l’Université de Montréal. L’auteur a autorisé l’Université de Montréal à reproduire et diffuser, en totalité ou en partie, par quelque moyen que ce soit et sur quelque support que ce soit, et exclusivement à des fins non lucratives d’enseignement et de recherche, des copies de ce mémoire ou de cette thèse. L’auteur et les coauteurs le cas échéant conservent la propriété du droit d’auteur et des droits moraux qui protègent ce document. Ni la thèse ou le mémoire, ni des extraits substantiels de ce document, ne doivent être imprimés ou autrement reproduits sans l’autorisation de l’auteur. Afin de se conformer à la Loi canadienne sur la protection des renseignements personnels, quelques formulaires secondaires, coordonnées ou signatures intégrées au texte ont pu être enlevés de ce document. Bien que cela ait pu affecter la pagination, il n’y a aucun contenu manquant. NOTICE This document was digitized by the Records Management & Archives Division of Université de Montréal. The author of this thesis or dissertation has granted a nonexclusive license allowing Université de Montréal to reproduce and publish the document, in part or in whole, and in any format, solely for noncommercial educational and research purposes. The author and co-authors if applicable retain copyright ownership and moral rights in this document. Neither the whole thesis or dissertation, nor substantial extracts from it, may be printed or otherwise reproduced without the author’s permission.
    [Show full text]
  • The Effect of Meconium and Amniotic Fluid on Alveolar Macrophage Function
    THE EFFECT OF MECONIUM AND AMNIOTIC FLUID ON ALVEOLAR MACROPHAGE FUNCTION A Thesis Submitted to the Graduate Faculty in Partial Fulfillment of the Requirements for the Degree of Master of Science in the Department of Pathology and Microbiology Faculty of Veterinary Medicine University of Prince Edward Island Sylvia J. Craig Charlottetown, P.E.I. June, 2003 © 2003. S. Craig Reproduced with permission of the copyright owner. Further reproduction prohibited without permission. National Library Bibliothèque nationale 1^1 of Canada du Canada Acquisitions and Acquisisitons et Bibliographic Services services bibliographiques 395 Wellington Street 395, rue Wellington Ottawa ON K1A0N4 Ottawa ON K1A 0N4 Canada Canada Your file Votre référence ISBN: 0-612-93864-6 Our file Notre référence ISBN: 0-612-93864-6 The author has granted a non­ L'auteur a accordé une licence non exclusive licence allowing the exclusive permettant à la National Library of Canada to Bibliothèque nationale du Canada de reproduce, loan, distribute or sell reproduire, prêter, distribuer ou copies of this thesis in microform, vendre des copies de cette thèse sous paper or electronic formats. la forme de microfiche/film, de reproduction sur papier ou sur format électronique. The author retains ownership of theL'auteur conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts from it Ni la thèse ni des extraits substantiels may be printed or otherwise de celle-ci ne doivent être imprimés reproduced without the author's ou aturement reproduits sans son permission. autorisation. In compliance with the Canadian Conformément à la loi canadienne Privacy Act some supporting sur la protection de la vie privée, forms may have been removed quelques formulaires secondaires from this dissertation.
    [Show full text]
  • (Prom) Refers to Membrane Rupture Before the Onset of Uterine Contractions (Previously Known As Premature Rupture of Membranes);
    • PRELABOR RUPTURE OF MEMBRANES (PROM) REFERS TO MEMBRANE RUPTURE BEFORE THE ONSET OF UTERINE CONTRACTIONS (PREVIOUSLY KNOWN AS PREMATURE RUPTURE OF MEMBRANES); • PRETERM PROM (PPROM) REFERS TO PROM BEFORE 37 WEEKS OF GESTATION. • IT IS RESPONSIBLE FOR, OR ASSOCIATED WITH, APPROXIMATELY ONE-THIRD OF PRETERM BIRTHS THE MANAGEMENT OF PPROM IS AMONG • : ●ACCURATE DIAGNOSIS IN PROBLEMATIC CASES ●EXPECTANT MANAGEMENT VERSUS INTERVENTION ●USE OF TOCOLYTICS ●DURATION OF ADMINISTRATION OF ANTIBIOTIC PROPHYLAXIS ●TIMING OF ADMINISTRATION OF ANTENATAL CORTICOSTEROIDS ●METHODS OF TESTING FOR MATERNAL/FETAL INFECTION ●TIMING OF DELIVERY INCIDENCE OF PPROM • 3 PERCENT OF PREGNANCIES • APPROXIMATELY 0.5 PERCENT OF PREGNANCIES <27 WEEKS, • 1 PERCENT OF PREGNANCIES 27 TO 34 WEEKS, • 1 PERCENT OF PREGNANCIES 34 TO 37 WEEKS THE STRENGTH AND INTEGRITY OF FETAL MEMBRANES DERIVE FROM EXTRACELLULAR MEMBRANE PROTEINS, • INCLUDING COLLAGENS, • FIBRONECTIN, • AND LAMININ. MATRIX METALLOPROTEASES (MMPS) DECREASE MEMBRANE STRENGTH BY INCREASING COLLAGEN DEGRADATION PATHOGENESIS SUBCLINICAL OR OVERT INFECTION, INFLAMMATION, MECHANICAL STRESS, BLEEDING INITIATE A CASCADE OF BIOCHEMICAL CHANGES THAT CULMINATE IN PROM CLINICAL FINDINGS RISK FACTORS • MATERNAL PHYSIOLOGIC • GENETIC • ENVIRONMENTAL FACTORS • A HISTORY OF PPROM IN A PREVIOUS PREGNANCY • GENITAL TRACT INFECTION • ANTEPARTUM BLEEDING • CIGARETTE SMOKING HAVE A PARTICULARLY STRONG ASSOCIATION WITH PPROM • POLYHYDRAMNIOS • ACUTE TRAUMA • SEVERAL GENETIC POLYMORPHISMS OF GENES RELATED TO INFECTION, INFLAMMATION, AND COLLAGEN DEGRADATION • FINDINGS ON PHYSICAL EXAMINATION — • DIRECT OBSERVATION OF AMNIOTIC FLUID • IF AMNIOTIC FLUID IS NOT IMMEDIATELY VISIBLE, THE WOMAN CAN BE ASKED TO PUSH ON HER FUNDUS, VALSALVA, OR COUGH TO PROVOKE LEAKAGE OF AMNIOTIC FLUID FROM THE CERVICAL OS. FOR PATIENTS WHO ARE NOT IN ACTIVE LABOR, EXAMINATION OF THE CERVIX AND VAGINA SHOULD BE PERFORMED USING A STERILE SPECULUM.
    [Show full text]
  • Danica Popovic.Qxd
    Jugoslov Med Biohem 2006; 25 (4): 403 DOI: 10.2298/JMB0604403P UC 577,1; 61 ISSN 0354-3447 Jugoslov Med Biohem 25: 403– 410, 2006 Nau~ni rad Scientific paper APPLICATION OF BIOMARKERS IN EVALUATION OF FETAL LUNG MATURITY Danica Popovi}1, Vojislav Miketi}2, Gorjana Matovi}1, Vuko Nikoli}1 1Centre for Clinical-Laboratory Diagnostics, Clinical Centre of Montenegro, Podgorica, Montenegro 2Clinic of Gynecology and Obstetrics, Clinical Centre of Montenegro, Podgorica, Montenegro Summary: In the process of maturation, alveolar epithelial cells produce surface-active material (surfac- tant) which consists mainly of phospholipids and, although to a significantly lesser degree, neutral lipids, pro- teins and carbohydrate. Pulmonary surfactant is synthesized in alveolar type-II granular pneumocytes and »packed« as lamellar bodies. Before delivery, the lamellar bodies diffuse through the bronchial tree into the amniotic fluid. Parameters which indicate the maturity of lungs, except the concentration of lamellar bodies, also are observed in the ratio against the quantity of surfactant with other components of the amniotic fluid (sphingomyelin and albumin). The study concerns the determination of the surfactant-to-albumin ratio and the lamellar body count in the amniotic fluid as predictors of fetal lung maturity. The research involved 90 preg- nant women with gestational age from 32 to 40 weeks. The samples of the amniotic fluid were obtained by amniocentesis and they were filtrated through special filters. The surfactant-to-albumin ratio was measured by the Fetal Lung Maturity II (FLM) test, on a TDX instrument (ABBOTT). The concentration of lamellar body count was measured on a hematology cell counter by the platelet channel, on the Cell Dyn 3700 instrument (ABBOTT).
    [Show full text]
  • NIH Public Access Author Manuscript Clin Obstet Gynecol
    NIH Public Access Author Manuscript Clin Obstet Gynecol. Author manuscript; available in PMC 2013 June 17. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Clin Obstet Gynecol. 2012 September ; 55(3): 722–730. doi:10.1097/GRF.0b013e318253b318. Antepartum Evaluation of the Fetus and Fetal Well Being ERICA O'NEILL, MD and JOHN THORP, MD Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina Abstract Despite widespread use of many methods of antenatal testing, limited evidence exists to demonstrate effectiveness at improving perinatal outcomes. An exception is the use of Doppler ultrasound in monitoring high-risk pregnancies thought to be at risk of placental insufficiency. Otherwise, obstetricians should proceed with caution and approach the initiation of a testing protocol by obtaining an informed consent. When confronted with an abnormal test, clinicians should evaluate with a second antenatal test and consider administering betamethasone, performing amniocentesis to assess lung maturity, and/or repeating testing to minimize the chance of iatrogenic prematurity in case of a healthy fetus. Keywords antenatal testing; fetal well-being; fetal movement counting; nonstress test; fetal lung maturity; Doppler ultrasound Introduction The primary goal of antenatal evaluation is to identify fetuses at risk for intrauterine injury and death so that intervention and timely delivery can prevent progression to stillbirth. Ideally, antenatal tests would decrease fetal death without putting large numbers of healthy fetuses at risk for premature delivery and the associated morbidity and mortality. Despite widespread use of many tests, limited evidence exists to demonstrate effectiveness at improving perinatal outcomes with application of these tests.
    [Show full text]
  • A Simple Method of Assessing Fetal Lung Maturity by Lamellar Body Concentration in Amniotic Fluid 1Jayaraman Nambiar, 2Muralidhar V Pai, 3Amruta C
    JSAFOG 10.5005/jp-journals-10006-1634 RESEARCH ARTICLE A Simple Method of Assessing Fetal Lung Maturity by Lamellar Body Concentration in Amniotic Fluid 1Jayaraman Nambiar, 2Muralidhar V Pai, 3Amruta C ABSTRACT INTRODUCTION Objective: To find out whether amniotic fluid lamellar body Respiratory distress syndrome (RDS) also known as concentrations (LBC) can predict neonatal respiratory distress hyaline membrane disease is the most common cause of syndrome (RDS) respiratory failure in the neonate.1 The risk of RDS rises Materials and methods: Amniotic fluid was obtained at the time in prematurity due to decreased production of surfactant. of cesarean section was sent to the laboratory for lamellar body Lamellar bodies (LB) are storage form of surfactant within concentrations in amniotic fluid. The lamellar body concentra- tions were analyzed and correlated with the incidence of RDS. type II pneumocytes and are actively secreted into the alveolar space and hence into the amniotic fluid. They Results: The incidence of RDS at different gestational age with an LBC cut off of 41,500 was studied. Among 220 patients are secreted from 28 weeks of gestation. The concentra- studied, Respiratory distress was seen in 53 (24.09%) of tion of lamellar bodies increases as the gestational age patients. There is a significant correlation between decreasing increases.2 Respiratory distress syndrome is a major cause lamellar body count in preterms and incidence of RDS. LBC of morbidity and mortality in preterm neonates. With the count has a sensitivity of 92.7 %, the specificity of 90 %, a positive-predictive value of 73% and a negative-predictive value advent of modern newborn care now, many pregnancies of 98% in predicting respiratory distress syndrome.
    [Show full text]